Insider Buy/Sell Details for the Biotechnology Industry — June 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (145)
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
777
Price
$2.48
Total Value
$1.93K
Shares Held After
2,533,845
% of Holdings
0.0%
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
63,985
Price
$2.47
Total Value
$158.04K
Shares Held After
2,533,068
% of Holdings
2.5%
ProQR Therapeutics N.V. (PRQR)
Filius Bart — Director
Shares
150,000
Price
$1.54
Total Value
$231.00K
Shares Held After
150,000
% of Holdings
100.0%
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
134
Price
$2.54
Total Value
$340.36
Shares Held After
2,469,083
% of Holdings
0.0%
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
75,047
Price
$2.55
Total Value
$191.37K
Shares Held After
2,468,949
% of Holdings
3.0%
Artiva Biotherapeutics, Inc. (ARTV)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
1,876
Price
$8.98
Total Value
$16.85K
Shares Held After
16,795,919
% of Holdings
0.0%
Phio Pharmaceuticals Corp. (PHIO)
Bitterman Robert J — Director
Shares
10,000
Price
$0.99
Total Value
$9.90K
Shares Held After
421,421
% of Holdings
2.4%
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
100
Price
$26.39
Total Value
$2.64K
Shares Held After
33,054
% of Holdings
0.3%
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
1,358
Price
$25.55
Total Value
$34.70K
Shares Held After
32,954
% of Holdings
4.1%
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
4,212
Price
$24.90
Total Value
$104.88K
Shares Held After
31,596
% of Holdings
13.3%
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
580
Price
$23.61
Total Value
$13.69K
Shares Held After
27,384
% of Holdings
2.1%
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
510
Price
$2.56
Total Value
$1.31K
Shares Held After
2,393,902
% of Holdings
0.0%
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
145,880
Price
$2.48
Total Value
$361.78K
Shares Held After
2,393,392
% of Holdings
6.1%
CG Oncology, Inc. (CGON)
Liu Brian Guan-Chyun — Director
Shares
371,085
Price
$66.87
Total Value
$24.81M
Shares Held After
1,886,236
% of Holdings
19.7%
Artiva Biotherapeutics, Inc. (ARTV)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
31,000
Price
$8.88
Total Value
$275.28K
Shares Held After
16,794,043
% of Holdings
0.2%
Passage BIO, Inc. (PASG)
Lynx1 Capital Management LP — 10% Owner
Shares
50,055
Price
$4.12
Total Value
$206.10K
Shares Held After
673,759
% of Holdings
7.4%
CalciMedica, Inc. (CALC)
Middleton Fred A — Director
Shares
248,972
Price
$0.80
Total Value
$200.00K
Shares Held After
1,063,272
% of Holdings
23.4%
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
100
Price
$27.77
Total Value
$2.78K
Shares Held After
26,804
% of Holdings
0.4%
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
3,400
Price
$26.98
Total Value
$91.73K
Shares Held After
26,704
% of Holdings
12.7%
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
3,000
Price
$25.98
Total Value
$77.94K
Shares Held After
23,304
% of Holdings
12.9%
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
2,891
Price
$25.22
Total Value
$72.91K
Shares Held After
20,304
% of Holdings
14.2%
Lite Strategy, Inc. (LITS)
Flynn James P — Director
Shares
25,000
Price
$0.86
Total Value
$21.39K
Shares Held After
125,000
% of Holdings
20.0%
Oncotelic Therapeutics, Inc. (OTLC)
Trieu Vuong — Director
Shares
115,000
Price
$0.04
Total Value
$5.17K
Shares Held After
93,884,319
% of Holdings
0.1%
Oncotelic Therapeutics, Inc. (OTLC)
Trieu Vuong — Director
Shares
75,000
Price
$0.04
Total Value
$3.38K
Shares Held After
93,769,319
% of Holdings
0.1%
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
425
Price
$25.91
Total Value
$11.01K
Shares Held After
17,413
% of Holdings
2.4%
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
1,969
Price
$24.84
Total Value
$48.91K
Shares Held After
16,988
% of Holdings
11.6%
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
6,836
Price
$24.12
Total Value
$164.88K
Shares Held After
15,019
% of Holdings
45.5%
BioCardia, Inc. (BCDA)
STERTZER SIMON H — Director
Shares
39,000
Price
$1.00
Total Value
$39.00K
Shares Held After
166,338
% of Holdings
23.4%
Immuneering Corp (IMRX)
Zeskind Benjamin J. — Director
Shares
2,400
Price
$4.56
Total Value
$10.95K
Shares Held After
2,315,252
% of Holdings
0.1%
Oncotelic Therapeutics, Inc. (OTLC)
Trieu Vuong — Director
Shares
65,000
Price
$0.04
Total Value
$2.92K
Shares Held After
93,694,319
% of Holdings
0.1%
Faeth Therapeutics, Inc. (FTH)
Parikh Anand Kiran — Director
Shares
2,806
Price
$19.76
Total Value
$55.45K
Shares Held After
764,234
% of Holdings
0.4%
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
356
Price
$23.95
Total Value
$8.53K
Shares Held After
8,183
% of Holdings
4.4%
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
3,329
Price
$23.28
Total Value
$77.50K
Shares Held After
7,827
% of Holdings
42.5%
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
1,583
Price
$22.40
Total Value
$35.46K
Shares Held After
4,498
% of Holdings
35.2%
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
1,118
Price
$20.82
Total Value
$23.28K
Shares Held After
2,915
% of Holdings
38.4%
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
1,797
Price
$20.23
Total Value
$36.35K
Shares Held After
1,797
% of Holdings
100.0%
BioCardia, Inc. (BCDA)
STERTZER SIMON H — Director
Shares
70,200
Price
$0.92
Total Value
$64.58K
Shares Held After
127,338
% of Holdings
55.1%
Oncotelic Therapeutics, Inc. (OTLC)
Shah Amit B. — CFO
Shares
20,000
Price
$0.05
Total Value
$1.00K
Shares Held After
378,837
% of Holdings
5.3%
Aditxt, Inc. (ADTX)
HRT FINANCIAL LP — 10% Owner
Shares
7,340,178
Price
$0.01
Total Value
$95.42K
Shares Held After
2,406,438
% of Holdings
305.0%
Cardiff Oncology, Inc. (CRDF)
PACE GARY W — Director
Shares
30,000
Price
$1.22
Total Value
$36.60K
Shares Held After
1,356,376
% of Holdings
2.2%
Cardiff Oncology, Inc. (CRDF)
Mohindru Mani — Director
Shares
24,703
Price
$1.21
Total Value
$29.89K
Shares Held After
24,703
% of Holdings
100.0%
IMMUCELL CORP /DE/ (ICCC)
te Boekhorst Paul Francis Olivier — Director
Shares
8,000
Price
$9.49
Total Value
$75.96K
Shares Held After
17,785
% of Holdings
45.0%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
800
Price
$0.96
Total Value
$768.00
Shares Held After
300,566
% of Holdings
0.3%
Pasithea Therapeutics Corp. (KTTA)
Coastlands Capital LP — 10% Owner
Shares
100,000
Price
$0.53
Total Value
$53.00K
Shares Held After
3,835,035
% of Holdings
2.6%
Nasus Pharma Ltd (NSRX)
Teleman Dan Benjamin — Director
Shares
6,550
Price
$3.10
Total Value
$20.30K
Shares Held After
163,541
% of Holdings
4.0%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
1,500
Price
$0.85
Total Value
$1.27K
Shares Held After
299,766
% of Holdings
0.5%
Oncotelic Therapeutics, Inc. (OTLC)
Trieu Vuong — Director
Shares
239,759
Price
$0.04
Total Value
$10.69K
Shares Held After
93,629,319
% of Holdings
0.3%
PROTHENA CORP PUBLIC LTD CO (PRTA)
SCULLY WILLIAM P — 10% Owner
Shares
20,000
Price
$7.90
Total Value
$157.99K
Shares Held After
756,000
% of Holdings
2.6%
NeuroSense Therapeutics Ltd. (NRSN)
Ben-Noon Alon — Chief Executive Officer
Shares
250,000
Price
$0.80
Total Value
$200.00K
Shares Held After
4,534,233
% of Holdings
5.5%
NeuroSense Therapeutics Ltd. (NRSN)
Eisenberg Or — Chief Financial Officer
Shares
250,000
Price
$0.80
Total Value
$200.00K
Shares Held After
1,504,050
% of Holdings
16.6%
Showing 1–50 of 145 transactions (page 1 of 3)